View Full Version : General Cancer News
- Cancer-related expenditures increase faster than any other area of health care: JAMA
- FXR can slow the growth of tamoxifen-resistant breast cancer cells: Study
- Wellstar International to install TMI Imaging system in Beverly Hills
- FDHN announces 2010 AGA Research Scholars
- After bad publicity, insurer to act early on ending practice of canceling policies of
- Neoprobe reports revenues of $2.7M for first-quarter 2010
- Imaging costs for Medicare cancer patients on the rise
- Three new biomarkers for ductal carcinoma in situ found
- WellPoint profits rise 51 percent amid scrutiny on several fronts
- HHS Secretary's statement on WellPoint's announcement to end practice of rescissions
- Power3 Medical Products to present four abstracts at International Congress of Alzhei
- AVEO Pharmaceuticals reports net loss of $14.4 million for first-quarter 2010
- Provectus reports on end-of-Phase 2 meeting with FDA on licensure of PV-10 for metast
- Women with family history of breast cancer face increase risk of ovarian cancer
- Immunogen reports a net loss of $12.1 million in third quarter 2010
- Study confirms MammaPrint's capabilities in determining patients likely to benefit fr
- Jumping elements in primates may have important consequences for studies of human gen
- HHS Secretary to host web chat to discuss impact of newly passed health insurance ref
- Update on BioSante cancer vaccine portfolio to be presented at BIO International Conv
- Leading experts deliver breast cancer updates at unique public forum
- McGill scientist discovers how one particular gene regulates epithelial cells
- Smoking can increase risk of second cancer in breast cancer survivors
- Obese women more likely to have breast cancer at later stage: Study
- ZIOPHARM reports a net loss of $17.7 million in first quarter 2010
- Research roundup: Managing nursing home patients, streamlining medical billing, finan
- New research suggests tumor-secreted exosomes inhibit immune response, enhance tumor
- BSGI improves breast cancer detection
- PEAK Surgical announces positive results from two PRECISE Clinical Studies for breast
- BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development
- Interim study results demonstrate anti-tumor activity of CytRx's INNO-206 in myeloma
- FDA issues advisory on prostate cancer drugs
- NIH awards UIC $10M grant to study health disparities among underserved, minority wom
- NIH awards Hutchinson Center $10.24M for research of breast cancer disparities in His
- Broccoli component sulforaphane targets and kills breast cancer stem cells
- Drive for expediency should not compromise care in breast cancer diagnosis, treatment
- Study comparing enteroscopy technologies finds SE quicker than DBE for examining smal
- Celsion reports $4.6 million net loss from operations for first-quarter 2010
- GTx reports net income of $44.3M for first-quarter 2010 compared with net loss of $11
- Aethlon Medical plans to initiate patient recruitment for cancer immunotherapy study
- Celldex reports net loss of $6.6 million for first-quarter 2010
- Popular diabetes drug works differently than thought
- Scientists discover key molecular mechanism in breast cancer metastasis
- FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis pat
- Principals of StemTroniX, Power3 Medical Products file patent application
- Survey reveals need for educating U.S. women about stroke symptoms
- Allos Therapeutics reports net loss of $20.5 million for first-quarter 2010
- C. R. Bard reaches definitive agreement to acquire SenoRx
- Whole body MRI helps physicians diagnose and treat breast cancer: Study
- Watson Laboratories files raloxifene hydrochloride tablet ANDA
- Genomic Health reports 22% revenue growth, 58% decrease in net loss for first-quarter
- Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010
- CU-Boulder develops inhalable vaccine for measles prevention
- Research reveals role of ovarian hormone progesterone in alteration of breast stem ce
- Ovarian hormone progesterone plays pivotal role in altering breast stem cells: PMH re
- Abraxis Bioscience first-quarter ABRAXANE revenue increases to $87.9 million
- A checklist to stay healthy at every age
- Natazia tablets receive FDA approval for prevention of pregnancy
- Progestins increase chances of cancer metastasizing, finds study
- Gene patenting policies affect patient access to testing for disease-causing genes: S
- New research examines coping and appraisal of disease-related pain
- NPWH launches ETIQ campaign to improve access to information about menopause, estroge
- Creator of California Tay-Sachs Disease Prevention Program among the honorees
- Discovery of new genetic clues to breast cancer
- Study: PDE5 inhibitors may increase permeability of blood brain barrier to Herceptin
- Double mastectomy best for long-term prognosis of breast cancer
- More genetic sites associated with increase in breast cancer risk discovered
- Enzon reports income from continuing operations of $20.8M for first-quarter 2010
- New combination therapy may help treat anti-estrogen resistant ER+ breast cancer
- Limiting fat intake to below 20% can reduce risk of breast cancer recurrence by 24%
- Minn. negotiators seek compromise to expand Medicaid while a nursing home tax and cut
- Quest initiates dosing in Phase I clinical trial with SL052 Photodynamic Therapy in p
- Exelixis first-quarter revenues increase to $42.2 million
- Bionovo reports net loss of $4.7M for first-quarter 2010
- Tensions escalate between Obama administration, health insurers
- New computer-based tool developed to benefit cancer patients
- Genetic tests represent future of cancer care for women
- Older women want more information about breast cancer, breast screening: Survey
- CTI to conduct phase II study of pixantrone in metastatic breast cancer through NCCTG
- Researchers develop new approach to immunotherapy of cancer
- 27-year-old sickle cell disease patient undergoes multiple joint replacement surgery
- CyGene Laboratories reports heightened interest in at-home genetic testing
- TechniScan awarded U.S. Patent covering design of 3-D, Warm Bath Ultrasound system
- Cyclacel Pharmaceuticals reports net loss of $5.1M for first-quarter 2010
- DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary
- New research to improve treatment for oesophageal and upper stomach cancer
- Measuring gene expression in healthy women may predict future breast cancer risk, say
- BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million
- Novartis employees and colleagues join together to raise money for community organiza
- Power3 Medical Products files provisional patent applications with USPTO
- EvoLife Laboratories participates in ONS Congress 2010 to assist nurses, caregivers
- United Spinal Association and ICS co-sponsor first annual conference to empower women
- Twenty rising juniors to create bras during summer break
- Saint John's Health Center Trustee receives 2010 Distinguished Medical Science Award
- Cancer 'epidemic' isn't happening
- Hawthorn announces licensing deal with University of Pittsburgh for novel monoclonal
- 152 research and training grants awarded to researchers at 93 institutions nationwide
- Woman with higher blood levels of IGF-I more likely to develop breast cancer: Study
- Abviva receives Japanese patent for Mammastatin Serum Assay
- Neoprobe gamma radiation detection systems featured in RSL peer review in American Jo
- Researchers discover biological pathway signature of ccRCC
- Generex Biotechnology's Phase I study data of AE37 for prostate cancer published
- University of Arkansas to host the 2010 Advances in Breast Cancer Research workshop
- ASCO first peek
- Wellpoint CEO Braly faces sharp criticism at shareholders meeting
- Research shows improved treatment of severe epilepsy reduces overall cost of the cond
- Mutation in BRCA1 tumor suppressor gene helps develop breast, ovarian cancer: Study
- 70% of oncologists and 60% of ob-gyns disagree with Task Force's mammogram recommenda
- British Columbians lead the way in battle against cancer
- Canadian Cancer Statistics 2010 focuses on care, support for dying patients
- Nine facilities in northern California region named Centers of Excellence in accelera
- Study demonstrates anti-prostate cancer properties of Modified Citrus Pectin
- Loved ones can fill in gaping blanks about brain cancer patients' well-being: Study
- Genentech to present new data for targeted cancer medicines at 46th ASCO
- Data from three Phase II clinical trials of PS-targeting antibody to be presented at
- 'Teachable moments' can reduce cancer risk in children of parents with mutations in t
- New data highlighting Pfizer's approach to cancer drug development to be presented at
- Researchers discover key gene that promotes development of common kidney cancer
- Nektar Therapeutics to present data of NKTR-102 Phase 2 clinical trial in ovarian can
- Provectus to present further positive data from PV-10 Phase 2 clinical trial for meta
- ZIOPHARM Oncology to present phase II data from PICASSO trial for soft tissue sarcoma
- Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presen
- Data on serum DNA blood tests for early detection of cancer to be presented at ASCO 2
- New data on ARIAD's AP24534 and ridaforolimus accepted for presentation at ASCO 2010
- Women exposed prenatally to BPA or DES at increased risk of breast cancer: Study
- Abviva receives new patent grant notifications for MSA technology
- Scientists develop DNA-vaccine that restricts supply of blood to tumours
- Delphinus Medical Technologies secures $8M in venture capital to commercialize SoftVu
- Regulators puzzling out what insurers must do under new health law
- ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO
- Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells
- State Roundup: Oklahoma, S.C. and Ill. facing tough choices on health costs
- RCSI researchers identify biomarker that can predict severity of breast cancer
- Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept
- Highlights from June 2010 issue of American Journal of Pathology
- Breast-conserving therapy is viable treatment option for African-American women: Rese
- Study assesses possible links between pain medications and recurrent breast cancer ri
- Positron Emission Mammography helps evaluate response to neoadjuvant chemotherapy: St
- Study finds improvement in detection of breast cancer in mammograms over 9-year perio
- Local businesswoman nominated for Outstanding Contribution to Breast Cancer Campaign
- Genentech uses Complete Genomics' sequencing service to compare primary lung tumor, a
- Local school nominated for Breast Cancer Campaign's School of the Year award
- Active charity supporter nominated for Breast Cancer Campaign's Fundraiser of the Yea
- Amgen announces European approval of Prolia
- IMRT leads to fewer cases of xerostomia than other types of radiation: AHRQ report
- First Edition: May 28, 2010
- Thyroid cancer gene marker
- Pancreatic cancer patients with circulating tumor cells tend to have worse outcomes:
- LCRF to donate $25,000 for lung cancer studies at TGen
- Health law implementation deadlines missed, GOP offers repeal bill
- Exposure in womb to BPA, DES increase offspring's risk of breast cancer
- Crowne Plaza Invitational at Colonial hosts second annual Pink Out to raise awareness
- Women who undergo bilateral oophorectomy tend to have smaller tumors
- IMRT avoids xerostomia, but effectiveness on controlling cancer unclear
- Free educational forum tailored to the needs of people diagnosed with breast cancer
- Elekta acquires Resonant Medical
- GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis
- Cancer patients should find ways to be physically active during and after treatment:
- Prototype breast cancer vaccine shows promising results on mice
- TapImmune signs Licensing Option agreement with Mayo Clinic for breast cancer vaccine
- FDA grants priority review status to Eisai's eribulin NDA
- Oncimmune develops new blood test to aid early detection of cancer
- Targeted monoclonal antibodies show promise for pancreatic and metastatic breast canc
- Genes influence AIAA side effect in breast cancer survivors
- Chronix Biomedical to launch new disease detection, monitoring service for cancer res
- Discovery provides new therapeutic target to prevent loss of brain function
- PMRT increases breast cancer patients' five-year overall survival by almost 50%: Stud
- Olive oil produces greater weight loss in breast cancer survivors: Researchers
- Extracts from peach and plum kill breast cancer cells, say AgriLife Research scientis
- Nanosponge delivery system more effective at reducing tumor growth than direct inject
- Researchers identify new therapeutic target for cognitive decline
- Bone-strengthening drug zoledronic acid can help fight breast cancer DTCs: Study
- Discovery reveals a new approach to target cancer
- Study provides personalized strategies to boost AIAA compliance in breast cancer pati
- BSGI effective for evaluating unclear mammographic or ultrasound findings
- ELLICSR research centre opened at UHN
- Wolverine Venture Fund participates in $8M series A round of financing for Delphinus
- China Medical Technologies fourth-quarter revenues down 29.3% to $25.7 million
- Chemotherapy-induced amenorrhea improves survival in premenopausal women with early s
- Life Technologies partners to create Genomic Cancer Care Alliance
- Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemo
- Antiemetic-regimen with fosaprepitant injection provides similar protection against C
- Bayer to present Phase I and II clinical trial data of Alpharadin in CRPC at 46th ASC
- Infinity announces Phase 2 clinical trial results of IPI-504 for NSCLC
- Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 20
- Fox Chase Cancer Center announces first-in-human bi-specific HER2/HER3 pathway target
- USC to present promising new findings in cancer research at 2010 ASCO
- New clinical research findings on oncology to be highlighted at ASCO 2010
- Multiple study data on Agendia's MammaPrint, BluePrint, and ColoPrint assays to be pr
- Phase Ib/II trial data for trastuzumab-DM1 in combination with pertuzumab presented a
- Celldex Therapeutics reports mature data from CDX-011 Phase 1/2 study in advanced bre
- Incyte presents additional results from INCB7839 Phase I/II trial for HER2-positive m
- bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index cl
- AMG 386 demonstrates antitumor activity in Phase 2 trial involving patients with recu
- Eisai's eribulin mesylate improves median OS compared with TPC in pre-treated metasta
- Bisphosphonates may cause poorer survival rate in women with early stage breast cance
- Arrhythmia Alliance launches 'Know Your Pulse' global awareness campaign on World Hea
- Clinical trial data of imetelstat in patients with breast cancer presented at ASCO an
- Chronix's serum DNA assays have potential to detect early stage breast cancer, prosta
- BioSante's GVAX CML Vaccine granted FDA Orphan Drug designation
- Promising clinical data on CDX-011 in metastatic melanoma presented at ASCO Annual Me
- Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at AS
- Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2
- Teen researches Artemesinin for cancer
- Lawsuit to be launched over breast cancer gene patent
- Interim data from multiple ongoing trials of XL147 PI3K inhibitor to be presented at
- ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma a
- Final results from Phase 1 trial of OGX-427 for treating solid tumors presented at AS
- Chronix' DNA blood tests detect prostate, breast cancer with 92% sensitivity and 100%
- GTx presents quality of life results from Ostarine Phase IIb study in cancer cachexia
- Genta presents tesetaxel dose-ranging trial results at ASCO 2010
- Researchers discover RAF oncogene that may drive aggressive forms of prostate cancer
- Findings from Abraxis BioScience's phase 3 ABRAXANE trial in patients with NSCLC pres
- Phase 2 Study: NKTR-102 holds great therapeutic potential for women with platinum-res
- Clarient granted U.K. patent for TLE3 biomarker
- New technique to prevent tumours developing in connection with stem cell transplantat
- Breast cancer research showcased at ASCO Annual Meeting
- Psychological intervention program teaches breast cancer patients how to cope with th
- Breast tomosynthesis holds promise for early breast cancer detection
- Myriad Pharmaceuticals announces strategic initiatives to focus on oncology pipeline
- Multiple presentations on nab-driven chemotherapy at 46th ASCO
- Stress-reducing psychological intervention helps increase quality of life among women
- University of Missouri researchers to investigate cadmium's potential for causing end
- Positive initial results from Nektar Therapeutics' NKTR-102 Phase 2 study for metasta
- NICE decides not to recommend lapatinib for women with advanced breast cancer
- Scientists discover how polyphenols present in red wine and green tea inhibit prostat
- Baylor Institute of Immunology Research receives nearly $35M as grants in 2009
- 22 Midwest facilities named Centers of Excellence in accelerated partial breast irrad
- EC approves Nivestim for prevention of FN
- Are Dead Cancer Cells Feeding Cancer's Spread?
- iCAD to supply CAD technology for mammography to VA, Department of Defense Hospitals
- Ashikari Breast Center to participate in TARGiT intra-operative radiotherapy trial
- Older breast cancer women in Scotland do not receive same level of treatment as young
- UAB researchers win grant to study metastasis of dead cancer cells
- CTT's Calmare Pain Therapy Treatment shows promise against CIPN
- SBUMC uses RapidArc radiotherapy technology to treat cancer patients
- Budget cuts, poor fiscal management threaten breast cancer screening for needy women
- Interpretation of multiple gene function may hold clue to autism
- Abraxis BioScience presents phase 3 trial data on metastatic malignant melanoma
- AVEO Pharmaceuticals presents tivozanib’s Phase 2 trial data at ASCO meeting
- HL survivors do not receive recommended cancer screening tests: Study
- Study results of genes regulated by ERB published in Journal of Biological Chemistry
- Eribulin mesylate drug may help extend lives of women with advanced breast cancer
- DRIVE4COPD initiative aims to raise awareness of COPD
- How Carly Fiorina can cure her hot-mic 'hair' gaffe (cancer survivor)
- New guideline to improve IHC testing for expression status of ER and PgR in breast ca
- ARBs increase risk of cancer: Study
- Nurse with enhanced clinical skills detects same breast abnormalities as surgeon
- Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at AS
- Telormedix initiates Phase I/II clinical study of TMX-101 for treating NMIBC
- UCB announces availability of Vimpat oral solution formulation
vBulletin® v3.8.7, Copyright ©2000-2024, vBulletin Solutions, Inc.